Trial Profile
Treatment of inflammatory bowel disease with vedolizumab: patient characteristics and clinical response.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 21 Aug 2015 New trial record